Extended follow-up of the Essential Pro paclitaxel drug-eluting balloon for in-stent restenosis
To the Editor, The use of drug-eluting balloons (DEB) represents a novel and growing alternative therapeutic strategy for patients with in-stent restenosis (ISR).1 A recent publication in REC: Interventional Cardiology presented the real-world safety and efficacy data on the use of the Essential Pro...
Saved in:
| Main Authors: | Lucio Padilla, Jorge Tello, Pablo Lamelas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Permanyer
2025-05-01
|
| Series: | REC: Interventional Cardiology (English Ed.) |
| Online Access: | https://recintervcardiol.org/en/index.php?option=com_content&view=article&id=2656 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Paclitaxel eluting stents versus bare metal stents restenosis
by: Ronald Aroche Aportela, et al.
Published: (2021-12-01) -
Seguimiento extendido del balón liberador de paclitaxel Essential Pro para reestenosis intrastent
by: Lucio Padilla, et al.
Published: (2025-05-01) -
Comparison of the Efficacy of Everolimus-Eluting Stents and Paclitaxel-Eluting Balloon Angioplasty for Coronary In-Stent Restenosis: A Systematic Review and Meta-Analysis
by: Zhili Wei, et al.
Published: (2025-06-01) -
Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon
by: Yasser Gaber Metwally, et al.
Published: (2024-12-01) -
Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study
by: Sacharias von Koch, et al.
Published: (2024-12-01)